Stockreport

Gilead to acquire cancer therapy developer Arcellx for up to $7.8 billion [Yahoo! Finance]

Arcellx, Inc.  (ACLX) 
PDF Gilead to acquire cancer therapy developer Arcellx for up to $7.8 billion [Read more]